Table 3.
Methodological Index of Non-randomized Studies checklist for quantitative studies
Authors | MINORS questions | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Q1a | Q2b | Q3c | Q4d | Q5e | Q6f | Q7g | Q8h | Q9i | Q10j | Q11k | Q12l | Total | |
Dengsø et al. (2021) [6] | 2 | 2 | 0 | 2 | 2 | 2 | 0 | 0 | 1 | 2 | 0 | 1 | 14 |
Janda et al. (2017) [32] | 2 | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
Sherman et al (2015) [33] |
2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
Engebreston et al. (2015) [5] | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
MINORS Methodological index of nonrandomized studies, NA not applicable
aA clearly stated aim
bInclusion of consecutive patients
cData was collected according to established protocol
dEndpoint appropriate to the aim of the study
eUnbiased assessment of the study endpoint
fFollow-up period appropriate of the study
gLoss to follow-up less than 5%
hProspective calculation of the study size
iAn adequate control group was used?
jStudied and control groups were managed at the same time
kBaseline equivalence of studied and control groups
lAdequate statistical analyses were used